DBVT Q4 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$511,000-94.2% YoY

Gross Profit

$511,000100.0% margin

Operating Income

-$24M-4669.5% margin

Net Income

-$23M-4503.9% margin

EPS (Diluted)

$-1.20

QoQ Revenue Growth

-52.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

-$453,000

Balance Sheet

Total Assets

$66M

Total Liabilities

$38M

Stockholders' Equity

$27M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$511,000	$9M	-94.2%
Gross Profit	$511,000	$9M	-94.2%
Operating Income	-$24M	-$12M	-100.2%
Net Income	-$23M	-$11M	-105.7%